The Current Status of Integrative Oncology in Korea

被引:2
作者
Kwag, Eun-Bin [1 ]
Kim, Soo-Dam [1 ]
Park, Ji Hye [2 ]
Park, So-Jung [1 ]
Jeong, Mi-Kyung [3 ]
Yoo, Hwa-Seung [2 ]
机构
[1] Daejeon Univ, Daejeon Korean Med Hosp, Daejeon, South Korea
[2] Daejeon Univ, Seoul Korean Med Hosp, Seoul, South Korea
[3] Korea Inst Oriental Med, Daejeon, South Korea
关键词
integrative oncology in Korea; integrative oncology; cancer patients; current status review; CANCER; MEDICINE;
D O I
10.1177/15347354211063809
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer is one of the leading causes of death worldwide, and Korea is no exception. Humanity has been fighting cancer for many years, and as a result, we now have effective treatments such as chemotherapy, radiation, and surgery. However, there are other issues that we are only now beginning to address, such as cancer patients' quality of life. Moreover, numerous studies show that addressing these issues holistically is critical for overall cancer treatment and survival rates. This paper describes how Korea is attempting to reduce cancer incidence and recurrence rates while also managing the quality of life of cancer patients. Integrative Oncology is the field that addresses these broad issues, and understanding the current state of integrative oncology in Korea is critical. The goal of this paper is to provide an overview of the current state of integrative oncology in Korea as well as to look ahead to future developments.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Optimizing Care: Integrative Oncology in Myeloproliferative Neoplasm
    Singh, Shagun
    Peshin, Supriya
    Larsen, Ashley
    Gowin, Krisstina
    CURRENT ONCOLOGY REPORTS, 2024, 26 (10) : 1135 - 1145
  • [32] Integrative oncology-how integrative medicine can be used in gynaecological oncology
    Tzschaschel, Marie
    Janni, Wolfgang
    Mergel, Franziska
    DEUTSCHE ZEITSCHRIFT FUR AKUPUNKTUR, 2024, 67 (03): : 137 - 143
  • [33] Current Status of Therapeutic Targeting of Developmental Signalling Pathways in Oncology
    Kiesslich, Tobias
    Berr, Frieder
    Alinger, Beate
    Kemmerling, Ralf
    Pichler, Martin
    Ocker, Matthias
    Neureiter, Daniel
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2012, 13 (11) : 2184 - 2220
  • [34] Molecular Imaging of Angiogenesis in Oncology: Current Preclinical and Clinical Status
    Florea, Alexandru
    Mottaghy, Felix M.
    Bauwens, Matthias
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
  • [35] Current status, challenges and prospects of antifouling materials for oncology applications
    Zhang, Yingfeng
    Sun, Congcong
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [36] Current status and future prospects of radiation oncology in Sri Lanka
    Ramanathan, Vijitha
    Balawardane, Jayantha
    Kumara, Appu Hennedige Dilip
    Sarasanandarajah, Sivananthan
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2022, 100 : 6 - 11
  • [37] Artificial intelligence for clinical oncology: current status and future outlook
    Jiang, Yuming
    Li, Ruijiang
    Li, Guoxin
    SCIENCE BULLETIN, 2023, 68 (05) : 448 - 451
  • [38] Recombinant human erythropoietin in oncology: current status and further developments
    Engert, A
    ANNALS OF ONCOLOGY, 2005, 16 (10) : 1584 - 1595
  • [39] Integrative Oncology: An International Perspective from Six Countries
    Toledano, Alain
    Rao, Santosh
    Frenkel, Moshe
    Rossi, Elio
    Bagot, Jean-Lionel
    Theunissen, Ingrid
    Diaz-Saez, Gualberto
    INTEGRATIVE CANCER THERAPIES, 2021, 20
  • [40] Addressing the need for personalizing music therapy in integrative oncology
    Rajendran, Tara
    JOURNAL OF INTEGRATIVE MEDICINE-JIM, 2022, 20 (04): : 281 - 283